TB-500 hasn’t proved thymosin beta-4’s healing results
Scientists made TB-500 while studying repair with thymosin beta-4. Animal tests usually used thymosin instead. Those findings don’t settle your treatment question.
What TB-500 contains, and what was actually tested
Scientists seeking repair made TB-500 from thymosin beta-4, called thymosin here. They wanted to study how that part might aid repair. Thymosin beta-4 is present through almost all your cells. Amino acids are what proteins are made from. Those small parts link together. Thymosin has a 43-amino-acid chain of these linked parts. Parts 17 through 23 of thymosin make up the copy. That part attaches to a protein involved in movement. TB-500 weighs about 889 daltons. Thymosin weighs about 4963 daltons. Those tiny protein weights are measured in daltons [1].
The two names refer to different treatments.
Sellers describe the short laboratory copy under that name. Papers about drug testing in sport use that name too. Repair studies, however, usually gave animals thymosin. Those results don't establish that the laboratory copy heals. Completed human comparison trials of the copy are missing. Online home-shot amounts haven’t proved benefit either [1].
Ask which treatment produced the result you're being told about. FDA hasn't approved TB-500 for patients. A sports ban covers the same treatment. FDA put TB-500 in Category 2 because of safety concerns. The group warned about safety while pharmacy ingredients were considered. People had asked FDA to allow that pharmacy use. Their names aren’t given here. They later withdrew the request. Withdrawal didn't establish permission for pharmacies to use that ingredient.
What the TB-500 peptide lacks from thymosin beta-4
TB-500 is a peptide, a short string of linked amino acids. Thymosin beta-4 is released near wounds by blood-clotting cells. Some immune system cells release thymosin as well. Actin is a cell protein used in movement and changes of shape. The part attaching to actin was used to make TB-500 [1].
Attaching to actin doesn't prove that the proposed treatment heals you.
When making TB-500, scientists add a small chemical part. The addition makes the lab-made treatment less prone to breaking apart. The body can still break down the treatment. Freezing and thawing the powder repeatedly can damage the contents too. Chemicals have lookup numbers in scientific books and libraries. A lookup number identifies a substance, rather than a bottle. There isn't one agreed number for the name TB-500. So the name alone can't confirm what a bottle holds.
Thymosin can break down into a separate scar-related substance. That substance may limit scarring and help small vessels grow. TB-500 lacks the part that makes this scar-related substance. Claims about that scar-related substance don't establish benefits from the proposed treatment. If your clinic mentions fewer scars, ask what treatment was tested.
What rats gained, and what volunteers did not test
These findings mostly concern thymosin beta-4, with narrow tests. The X-ray work examined proteins, without treating any injury. Researchers observed a 1:1 pairing between thymosin beta-4 and actin. That means one protein of each kind attached [2]. Wound researchers gave rats thymosin beta-4 for deep skin cuts. Salt water was given to the comparison rats. At four days, treated rats grew 42% more skin. The increase was up to 61% at seven days [3]. These percentages compare new skin growth in the two groups. The figures don't give the share of a wound covered over. Mice had an artery blocked to injure their hearts. With thymosin beta-4, heart cells died less and pumping improved [4].
Those animals received thymosin, rather than the proposed laboratory copy.
Human volunteers were healthy, so healing wasn't tested. Phase 1 means the first stage of testing human safety. The study divided 40 people into groups by chance. Some received thymosin beta-4; others received a placebo, similar treatment without the tested protein. Amounts of thymosin beta-4 reached 1260 milligrams [5]. Reported problems were few, and described as mild or moderate. The summary doesn't say which symptoms people experienced. Researchers continued the planned increases without harm requiring a stop. TB-500 hasn't completed a human trial with a comparison group [1].
You can read about skin and eye tests linked to TB-500. The wound findings behind TB-500 claims don't settle treatment for people. The cell-movement tests linked to TB-500 explain what researchers observed. These include experiments that gave thymosin.
What FDA discussion does for TB-500 permission
TB-500 has no FDA approval for treating people. Athletes face a prohibition from the World Anti-Doping Agency. FDA placed TB-500 among Category 2 ingredients with safety concerns. People had proposed the ingredient for pharmacy-made medicine. FDA now shows that proposal as withdrawn. The proposal concerned TB-500, made from part of thymosin beta-4 [6]. The TB-500 ingredient-rule answers explain the unanswered pharmacy question. See also whether TB-500 has FDA approval.
A withdrawn proposal doesn't assure you that shots are safe.
At the July 23-24, 2026 meeting, FDA advisers discussed TB-500 [6][7]. The topic was pharmacy ingredients. As of September 2026, their votes hadn't been published by FDA.
What changes did TB-500 researchers hope to find?
The work mainly treated animals or cells in dishes. Researchers examined thymosin beta-4 and the part copied into TB-500. They looked for wounds closing, more vessels, and less scarring. They also studied inflammation, the body's sore, swollen response to injury. Other experiments examined damaged hearts, eyes, and brains [10]. TB-500 hasn't proved these gains in injured people [1].
What part of thymosin beta-4 goes into TB-500?
The laboratory copy contains parts 17 through 23 of thymosin beta-4. Thymosin has a 43-amino-acid chain of linked protein parts. The copied part attaches to a protein helping cells move. Suppliers describe the treatment for laboratory research and animal use. Most repair findings followed treatment with thymosin instead [1].
What do the letters TB in TB-500 mean?
TB refers to thymosin beta, from the name thymosin beta-4. Research writers call the short laboratory copy TB-500. Research papers and animal suppliers use that name. The name doesn't spell out an additional official chemical name [1].
What home users felt after their shots
People who tried TB-500 themselves described changes and complaints after use. They called their home use research. They weren't describing participation in a study. No trial has checked their accounts. You can read about felt relief and reported problems. Healing from those home shots remains unproved. Most studies instead gave thymosin beta-4.